Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -223,123 | -258,746 | -245,595 | -221,863 | -169,069 |
| Depreciation Amortization | 11,287 | 9,375 | 7,098 | 6,266 | 5,373 |
| Accounts payable and accrued liabilities | -10,351 | 6,067 | N/A | N/A | -4,827 |
| Other Working Capital | -8,263 | 5,671 | 13,822 | 6,076 | -3,386 |
| Other Operating Activity | 40,436 | 27,909 | 29,759 | 31,379 | 50,746 |
| Operating Cash Flow | $-190,014 | $-209,724 | $-194,916 | $-178,142 | $-121,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -440 | -5,862 | -16,436 | -8,358 | -7,620 |
| Net Acquisitions | N/A | N/A | N/A | 42,726 | N/A |
| Purchase Of Investment | -276,553 | -245,886 | -390,920 | -376,327 | -245,875 |
| Sale Of Investment | 380,760 | 383,454 | 309,326 | 272,894 | 272,443 |
| Other Investing Activity | 0 | 0 | -36 | -261 | -95 |
| Investing Cash Flow | $103,767 | $131,706 | $-98,066 | $-69,326 | $18,853 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 185,739 | 208,401 | 155,335 | 37,681 |
| Common Stock Repurchased | -67 | N/A | N/A | -47 | N/A |
| Other Financing Activity | 215 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $148 | $185,739 | $208,401 | $155,288 | $37,681 |
| Beginning Cash Position | 164,997 | 57,276 | 141,857 | 234,037 | 298,666 |
| End Cash Position | 78,898 | 164,997 | 57,276 | 141,857 | 234,037 |
| Net Cash Flow | $-86,099 | $107,721 | $-84,581 | $-92,180 | $-64,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | -190,014 | -209,724 | -194,916 | -178,142 | -121,163 |
| Capital Expenditure | -440 | -5,862 | -16,436 | -8,358 | -7,620 |
| Free Cash Flow | -190,454 | -215,586 | -211,352 | -186,500 | -128,783 |